| Date | Filer | Title | Filing | Type | Shares Traded | Price | Total Held |
|---|---|---|---|---|---|---|---|
| Jun 18, 2024 |
Director
Trans History: 19
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 30,000 | -- | 30,000 |
| Jun 18, 2024 |
Director
Trans History: 12
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 30,000 | -- | 30,000 |
| Jun 18, 2024 |
Director
Trans History: 12
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 30,000 | -- | 30,000 |
| Jun 18, 2024 |
Director
Trans History: 10
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 30,000 | -- | 30,000 |
| Jun 18, 2024 |
Director
Trans History: 4
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 30,000 | -- | 30,000 |
| Jun 18, 2024 |
Director
Trans History: 15
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 30,000 | -- | 30,000 |
| Jun 18, 2024 |
Director
Trans History: 9
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 30,000 | -- | 30,000 |
| Jun 18, 2024 |
Director
Trans History: 3
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 30,000 | -- | 30,000 |
| Jun 05, 2024 |
Director, PRESIDENT AND CEO
Trans History: 32
|
Director, PRESIDENT AND CEO | Form 4 | Other acquisition or disposition | -- | -- | 502 |
| Jun 03, 2024 |
CHIEF MEDICAL OFFICER
Trans History: 14
|
CHIEF MEDICAL OFFICER | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 16,000 | -- | 48,245 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.